• Follow Us On : 

Appier Named in CB Insights’ Second Annual AI 100 Companies


Redaksi | Kamis,19 Januari 2017 - 23:23:43 WIB
Dibaca: 281 kali 
Appier Named in CB Insights’ Second Annual AI 100 Companies List recognizes the world's top 100 private companies working on ground-breaking artificial intelligence technology

SINGAPORE - Media OutReach - December 19, 2017 - Appier, a leading artificial intelligence (AI) company, has been named in CB Insights' AI 100 Companies 2018, the second time it has made the list. Announced at the recent CB Insights A-ha! conference in San Francisco, the AI 100 accolade recognizes promising private companies from around the world working on ground-breaking AI technology.

"We're delighted to be named for the second year running in CB Insight's AI 100. This is great recognition for our continued progress in the enterprise AI arena. 2017 has been a milestone year for us, not only did we celebrate our 5th anniversary as a company, but we also brought on board new notable investors and increased the number of valuable customers we serve to over 1,000," said Chih-Han Yu, CEO and co-founder of Appier.

"This year also saw us expand our presence in Asia with new offices, extend our R&D team to Singapore and make significant progress with Aixon, our AI-based data intelligence platform for enterprises. In addition, we've boosted our management line-up with experienced leaders. We look forward to more exciting developments in 2018."

Appier's Series C round of investment brought in US$33 million and more importantly market reach from SoftBank Group, LINE Corporation, NAVER Corporation, EDBI and AMTD Group. The new additions to Appier's executive team included Sean Chu, Chief Strategy Officer: Junde Yu, Chief Business Officer; and Charles Ng, Vice President for Enterprise AI. The company opened new offices in Osaka in July and Bangkok in May this year.

Appier also made headway with Aixon, launching it in Japan and sealing new customers such as LIFULL Co., one of Japan's largest real estate and housing information services. (riauone).


Akses Wahanariau.com Via Mobile m.Wahanariau.com
Untuk Berbagi Berita / Informasi / Peristiwa
Silahkan SMS ke nomor HP : 085271472010
atau email ke alamat : [email protected]
Harap camtumkan detail data diri Anda
Pengutipan Berita dan Foto, Cantumkan Wahanariau.com Sebagai Sumber Tanpa Penyingkatan
TULIS KOMENTAR
BERITA TERKAIT
Kamis,26 Juli 2018 - 14:17:05 WIB

Appier Strengthens AI Team with New Chief Artificial Intelligence Scientist

TAIWAN - Media OutReach - July 26 2018 - Appier, a leading artificial intelligen

Rabu,28 Februari 2018 - 09:42:51 WIB

Appier's Aixon Connects to Google Advertising Platforms

Connection enables Appier's enterprise customers to seamlessly run their campaigns directly from

Selasa,10 April 2018 - 14:47:58 WIB

Appier Brings AI-driven Insights To LINE With Aixon Integration

Integration will also enable real-time, cross-platform marketing for LINE Business Connect enterpris

Jumat,08 Juni 2018 - 20:13:05 WIB

Appier Wins Most Promising AI Solution Category of the NWA Information Management Awards 2018

Award established Appier as Asia's leader in AI in APAC SINGAPORE - Media OutReach -

Selasa,10 April 2018 - 11:48:57 WIB

Appier Report Shows How Marketers can Navigate the Fragmented Digital Consumer Journey with Artificial Intelligence

Rapid adoption of smartphones and tablets and multi-device ownership has complicated the online user

Selasa,07 Agustus 2018 - 13:15:17 WIB

Appier Launches AI-driven Proactive Marketing Automation Platform AIQUA

TAIWAN - August 7, 2018 - Appier, a leading artificial intelligence (AI) company, today an

BERITA LAINNYA
Rabu,15 Agustus 2018 - 00:28:28 WIB

More than 400 IT Professionals Joined CLOUDSEC Hong Kong 2018

CHINA - 14 August 2018 - More than 400 professionals from Hong Kong and Macau today joined CLOUDSEC

Rabu,15 Agustus 2018 - 00:22:40 WIB

Avnet Memperluas Jaringan dengan Microchip

Dinobatkan sebagai Mitra Pemasaran Global bagi Microsemi Portfolio   PHOENIX - 14 AGUSTUS 201

Selasa,14 Agustus 2018 - 00:01:23 WIB

Sihuan Pharmaceutical’s Self-Developed Innovative Oncology Drug Pirotinib Commenced Phase II Clinical Trial in China

Led by Top Oncologist Professor Wu Yilong Expected to Commence Phase III Clinical Trial in 2H2019. D

BERGABUNG DI SINI
KABAR POPULER
IKUTI BERITA KAMI